Viewing nowNeocita Tablet 25mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Nokshim Pharmaceuticals Co., Ltd.

MFDS item code 202101812 · Approved 2021.02.24 · Insurance code 643606100
Improvement of blood sugar control in type 2 diabetes
This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be used alone, but if the patient has no prior experience in diabetes treatment and finds it difficult to control blood sugar levels with monotherapy, it can be used in combination with metformin. Additionally, if blood sugar control is insufficient with monotherapies such as sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can also be combined for treatment. In cases of combination therapy where blood sugar control is still insufficient, adding this medication can enhance effectiveness. By allowing flexible dosing in various scenarios, it helps improve blood sugar control.
This medication is administered once daily at a dose of 100 mg, with a maximum daily dose of 100 mg. It can be taken regardless of meals. Dosage adjustment for patients with renal impairment: 1. For mild renal impairment (eGFR 60-90 mL/min/1.73 m2), no dosage adjustment is necessary. 2. For moderate renal impairment (eGFR 45-60 mL/min/1.73 m2), no dosage adjustment is necessary.
This medication may cause serious allergic reactions in some patients; if symptoms such as rash, difficulty breathing, or swelling of the face or neck occur, discontinue use immediately and consult a physician. Pancreatitis, which is inflammation of the pancreas, may occur during the use of this medication; if sudden abdominal pain, nausea, or vomiting occurs, visit a hospital immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication. Patients with decreased kidney function may need a dosage adjustment; therefore, it is crucial to have kidney function tests regularly before and during treatment. During the use of this medication, side effects such as upper respiratory infections, rhinitis, headaches, and diarrhea may occur; if symptoms are severe, consult a doctor. There may be an increased risk of hypoglycemia if this medication is taken with other blood sugar-lowering agents, particularly insulin or sulfonylureas, so blood sugar levels should be monitored closely. If severe joint pain or skin blisters or rashes occur while taking this medication, inform a physician immediately, and if necessary, the medication may be discontinued. It is recommended that pregnant or nursing women do not use this medication, and safety for children under 18 years has not been established. Elderly patients may have decreased kidney function, necessitating dosage adjustments and kidney function tests. In the case of overdose, gastrointestinal removal of the medication and clinical monitoring, including an ECG, are necessary, and some removal may occur through hemodialysis. This medication has minimal drug interactions, but caution is needed when taken with certain medications, so inform your physician of any other drugs being used.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air and humidity exposure, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness and prevent degradation.
Pink, round, bilaterally convex film-coated tablet
28 tablets/box [(14 tablets/PTPX2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Nokshim Pharmaceuticals Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.